Drug-loaded exosomes targeting liver cancer, rapid preparation method and application thereof
CN115350282BActive Publication Date: 2024-11-05BEIJING WEICHUANG TIANCHENG PHARMACEUTICAL TECHNOLOGY CO LTD
9 Cites 0 Cited by
Patent Information
- Application Number
- CN202210903326.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-07-29
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2042-07-29
Smart Images

Figure CN115350282B_ABST
Abstract
The present invention discloses drug-loaded exosomes targeting liver cancer, a rapid preparation method and its application, and belongs to the field of biomedical technology. The present invention uses exosomes derived from human umbilical cord mesenchymal stem cells MSC as carriers, and loads traditional chemotherapy drugs doxorubicin into them through ultrasound assistance to obtain exosomes with high drug loading, and then uses neuraminidase to treat the exosomes, and after the enzyme catalysis hydrolyzes sialic acid, a large amount of galactose or N-acetylgalactosamine residues are exposed on the surface to obtain desialylated drug-loaded exosomes, which increases its binding ability to ASGPR on the surface of liver tumors. The present invention obtains exosomes loaded with doxorubicin drugs that can effectively target liver cancer cells with a drug loading of up to 25%, and the therapeutic effect of hepatocellular carcinoma can be improved by up to 167%. The drug-loaded exosomes targeting liver cancer of the present invention have better biocompatibility, low cytotoxicity, liver cancer targeting, and are short in preparation time, simple in method, and easy to use.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Hydrophobic anticancer medicinal preparation on basis of exosome
CN102349998A
Exocrine body as well as preparation method and application thereof as tumor vaccine
CN105132386A
Compositions and methods for stimulating natural killer cells
CN113366023A
Liver targeted drug-loaded exosome, application and drug for treating liver diseases
CN113388571A
Immune cell co-expressing IL-21 and hrCD16 chimeric receptor and application thereof
CN113528452A
